TherapeuticsMD (TXMD) Assets (2010 - 2026)
TherapeuticsMD's Assets came in at $37.53 million for Q2 2026, down 2.5% from $38.5 million a year earlier and down 0.1% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, TherapeuticsMD's Assets was $37.66 million, down 3.0% from FY2024.
- Assets has declined in each of the last six years, with a five-year compound annual growth rate of -27.0% (FY2020 to FY2025).
- Going back by year, Assets was $38.82 million in FY2024 (-10.4%), $43.31 million in FY2023 (-52.1%), $90.46 million in FY2022 (-46.6%) and $169.47 million in FY2021 (-6.7%).
- The Q2 2026 figure represents the lowest quarterly Assets since Q4 2012.
- Year-over-year, Assets has declined for 19 consecutive quarters, with an average decline of 6.8% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2021 (growth of 18.2%), and the weakest in Q2 2023 (a decline of 63.3%).
- Business Quant data shows TXMD's Assets at $37.58 million (Q1 2026), $37.66 million (Q4 2025) and $38.67 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 37.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.53 Mn |
| Mar 31, 2026 | 37.58 Mn |
| Dec 31, 2025 | 37.66 Mn |
| Sep 30, 2025 | 38.67 Mn |
| Jun 30, 2025 | 38.50 Mn |
| Mar 31, 2025 | 38.24 Mn |
| Dec 31, 2024 | 38.82 Mn |
| Sep 30, 2024 | 39.55 Mn |
| Jun 30, 2024 | 40.13 Mn |
| Mar 31, 2024 | 42.09 Mn |
| Dec 31, 2023 | 43.31 Mn |
| Sep 30, 2023 | 50.49 Mn |
| Jun 30, 2023 | 53.69 Mn |
| Mar 31, 2023 | 59.60 Mn |
| Dec 31, 2022 | 90.46 Mn |
| Sep 30, 2022 | 133.91 Mn |
| Jun 30, 2022 | 146.20 Mn |
| Mar 31, 2022 | 133.38 Mn |
| Dec 31, 2021 | 169.47 Mn |
| Sep 30, 2021 | 209.63 Mn |
API Access
TherapeuticsMD Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();